Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
JMIR Cancer
|
April 25, 2025
Co-Designing Priority Components of an mHealth Intervention to Enhance Follow-Up Care in Young Adult Survivors of Childhood Cancer and Health Care Providers: Qualitative Descriptive Study
Sharon H J Hou, Brianna Henry, Rachelle Drummond, et al.
The Lancet. Oncology
|
June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Craig Erker, Benita Tamrazi, Tina Y Poussaint, et al.
Journal of Neuro-Oncology
|
January 27, 2021
Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers
Mariko DeWire, Craig Erker, Trent R Hummel, et al.
Current Oncology (Toronto, Ont.)
|
July 26, 2024
Canadian Consensus for Treatment of BRAF <i>V600E</i> Mutated Pediatric and AYA Gliomas
Craig Erker, Magimairajan Issai Vanan, Valérie Larouche, et al.
Frontiers in Oncology
|
January 8, 2021
Canadian Pediatric Neuro-Oncology Standards of Practice
Julie Bennett, Craig Erker, Lucie Lafay-Cousin, et al.
Journal of Neuro-Oncology
|
March 5, 2024
Impact of trametinib on the neuropsychological profile of NF1 patients
Eve Lalancette, Édith Cantin, Marie-Ève Routhier, et al.
Pediatric Blood & Cancer
|
March 13, 2026
Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach
Patricia Orduña, Rose Daynielle Cansanay, Craig Erker, et al.
NPJ Precision Oncology
|
August 14, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon
Cameron Crowell, Ziwen Zhu, Yingxiang Li, et al.
Neuro-Oncology
|
May 13, 2022
Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry
Allison L Bartlett, Adam Lane, Brooklyn Chaney, et al.
Neuro-Oncology
|
May 19, 2026
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Dorsa Sadat Kiaei, Maxime Caru, Valérie Larouche, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
JMIR Cancer
|
April 25, 2025
Co-Designing Priority Components of an mHealth Intervention to Enhance Follow-Up Care in Young Adult Survivors of Childhood Cancer and Health Care Providers: Qualitative Descriptive Study
Sharon H J Hou, Brianna Henry, Rachelle Drummond, et al.
The Lancet. Oncology
|
June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Craig Erker, Benita Tamrazi, Tina Y Poussaint, et al.
Journal of Neuro-Oncology
|
January 27, 2021
Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers
Mariko DeWire, Craig Erker, Trent R Hummel, et al.
Current Oncology (Toronto, Ont.)
|
July 26, 2024
Canadian Consensus for Treatment of BRAF <i>V600E</i> Mutated Pediatric and AYA Gliomas
Craig Erker, Magimairajan Issai Vanan, Valérie Larouche, et al.
Frontiers in Oncology
|
January 8, 2021
Canadian Pediatric Neuro-Oncology Standards of Practice
Julie Bennett, Craig Erker, Lucie Lafay-Cousin, et al.
Journal of Neuro-Oncology
|
March 5, 2024
Impact of trametinib on the neuropsychological profile of NF1 patients
Eve Lalancette, Édith Cantin, Marie-Ève Routhier, et al.
Pediatric Blood & Cancer
|
March 13, 2026
Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach
Patricia Orduña, Rose Daynielle Cansanay, Craig Erker, et al.
NPJ Precision Oncology
|
August 14, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon
Cameron Crowell, Ziwen Zhu, Yingxiang Li, et al.
Neuro-Oncology
|
May 13, 2022
Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry
Allison L Bartlett, Adam Lane, Brooklyn Chaney, et al.
Neuro-Oncology
|
May 19, 2026
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Dorsa Sadat Kiaei, Maxime Caru, Valérie Larouche, et al.
Page
of 4